David Shaw’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Buy
1,177,421
+835,783
+245% +$76.4M 0.05% 408
2026
Q1
$12.7M Buy
341,638
+51,347
+18% +$1.64M 0.01% 1440
2025
Q4
$5.86M Buy
290,291
+55,917
+24% +$1.35M ﹤0.01% 2182
2025
Q3
$7.06M Buy
+234,374
New +$5.08M ﹤0.01% 1935
2024
Q2
Sell
-52,443
Closed -$611K 4444
2024
Q1
$650K Sell
52,443
-275,429
-84% -$4.59M ﹤0.01% 3353
2023
Q4
$8.7M Buy
327,872
+54,879
+20% +$1.6M 0.01% 1473
2023
Q3
$12.5M Sell
272,993
-323,301
-54% -$15M 0.01% 1128
2023
Q2
$24.6M Buy
596,294
+315,645
+112% +$10.4M 0.03% 768
2023
Q1
$8.71M Buy
+280,649
New +$9.04M 0.01% 1480
2022
Q2
Sell
-88,844
Closed -$903K 5298
2022
Q1
$903K Buy
+88,844
New +$1.14M ﹤0.01% 3999

Other funds holding AEHR

David Shaw's AEHR Position: Q2 2026 in Review

David Shaw increased its Aehr Test Systems (AEHR) stake by 245% in Q2 2026, buying an estimated $76.4M and bringing the position to 1,177,421 shares worth $113M. The position accounts for 0.05% of the portfolio, ranked #408.

David Shaw first reported a position in AEHR in Q1 2022 and has held it in 10 quarters since. 261 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • David Shaw held 1,177,421 shares of Aehr Test Systems worth $113M as of Q2 2026.
  • David Shaw bought 835,783 Aehr Test Systems shares in Q2 2026, an estimated $76.4M.
  • Aehr Test Systems made up 0.05% of David Shaw's portfolio in Q2 2026, its #408 holding.
  • David Shaw first reported a position in Aehr Test Systems in Q1 2022 and has held it in 10 quarters since.
  • 261 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.